A 24 yrs female ingested acetamiprid insecticide of about 5 gm. give me the management plan

Reading File

Finding Sources

Searching PubMed

acetamiprid poisoning management treatment

Searching the Web

acetamiprid insecticide poisoning clinical management treatment protocol

Reading File

Reading Article

Finding Sources

I now have enough information to compose a comprehensive, well-sourced management plan. Here is the full response:

Management of Acetamiprid (Neonicotinoid) Poisoning - 5g Ingestion in a 24-Year-Old Female

Background and Mechanism

Acetamiprid is a neonicotinoid insecticide structurally similar to nicotine. It acts as an agonist at nicotinic acetylcholine receptors (nAChRs), with higher affinity for insect CNS receptors than mammalian ones - this is why human toxicity is generally less severe than organophosphate poisoning. However, at higher doses (as in this case), significant mammalian nicotinic effects can occur.

There is NO specific antidote. All management is supportive.

Tintinalli's Emergency Medicine, p. 1346

Estimated Severity

5g of pure acetamiprid is a significant dose; however, commercial formulations are typically 5-20% concentration, so the actual active ingredient ingested may be ~250mg-1g
WHO classifies acetamiprid as Class II (Moderately Hazardous)
Case reports describe severe toxicity including seizures, respiratory failure, AKI, CNS depression, and metabolic acidosis - even from smaller volumes [PMID: 40115001, PMID: 37727219]
Treat as a potentially serious ingestion requiring ICU-level monitoring

Step-by-Step Management Plan

1. Immediate Stabilization (First 30 minutes)

Airway, Breathing, Circulation (ABCs)

Assess GCS and airway protective reflexes
Apply oxygen via face mask; SpO2 target >95%
Establish two large-bore IV lines
Continuous cardiac monitoring (ECG) and pulse oximetry
12-lead ECG - look for QTc prolongation
Position in left lateral decubitus if consciousness is impaired

2. Decontamination

Gastric Lavage

If the patient presents within 1 hour of ingestion and is conscious/airway is protected: consider gastric lavage with a large-bore orogastric tube
NOT indicated if the patient is drowsy, seizing, or has lost airway reflexes (intubate first)

Activated Charcoal (AC)

Give 50g single dose of activated charcoal orally/via NG tube if the patient is conscious and cooperative, within 1-2 hours of ingestion
Do NOT give in an obtunded patient without a protected airway
AC is the preferred GI decontamination method

Cathartic/Purgation

Sorbitol or sodium sulphate may be co-administered with AC to speed GI transit (one dose only)

3. Clinical Monitoring and Lab Workup

Order the following immediately:

Investigation	Rationale
ABG (arterial blood gas)	Metabolic acidosis, hyperlactacidemia (seen in case reports)
CBC, BMP (renal panel)	AKI monitoring
Liver function tests	Hepatotoxicity possible
Serum lactate	Elevated in severe poisoning
Blood glucose	Hypoglycemia possible
CPK/CK	Rhabdomyolysis screening
Urinalysis	Myoglobinuria, AKI
Serum electrolytes including Mg²+	Arrhythmia risk
12-lead ECG	QTc prolongation, arrhythmia
Urine/serum toxicology screen	Exclude coingestants

4. Supportive Care (Targeted by Symptom)

GI Symptoms (nausea, vomiting)

Ondansetron 4-8mg IV for antiemetic control
IV fluids (Ringer's lactate or normal saline) for hydration - run at maintenance unless hypotensive

Neurological (seizures, muscle weakness, tremors)

Seizures: Lorazepam 2-4mg IV as first-line; escalate to phenobarbital/levetiracetam if refractory
Continuous EEG monitoring if seizures persist or mental status is depressed

Hypothermia

Active rewarming measures (blankets, warmed IV fluids) if core temp <36°C
Monitor with rectal/core temperature probe

Respiratory Failure

Early intubation if GCS <8 or deteriorating
Mechanical ventilation with lung-protective strategy if ARDS develops

Hypotension

IV fluid bolus 500mL NS as first step
Vasopressors (norepinephrine) if fluid-refractory hypotension

Rhabdomyolysis (if CK elevated)

Aggressive IV hydration (target urine output 1-2 mL/kg/hr)
Urinary alkalinization if severe

5. Advanced Interventions (If Severe)

Based on the case report of acetamiprid + pyridaben poisoning [PMID: 37727219], the following were used with success in a critically ill patient:

Hemoperfusion (HP): 24-hour hemoperfusion was used to enhance elimination
Continuous Renal Replacement Therapy (CRRT): Used for metabolic acidosis, AKI, and fluid overload
Indications: Use HP/CRRT if the patient develops severe metabolic acidosis, AKI with oliguria, or refractory hemodynamic instability

Note: Routine use of hemodialysis/hemoperfusion is not established for acetamiprid - these are reserved for severe/refractory cases.

6. Psychiatric Evaluation

Since this is an intentional ingestion in a 24-year-old, a formal psychiatric assessment is mandatory before discharge
Involve psychiatry/mental health team once the patient is medically stabilized
Maintain safe environment; 1:1 nursing observation
Screen for depression, suicidal ideation, prior attempts

7. Disposition

Severity	Disposition
Mild (GI symptoms only, stable vitals)	Observe in ED x 6-8 hours; admit if no improvement
Moderate (altered sensorium, persistent vomiting, CK elevation)	Admit to monitored ward/step-down unit
Severe (seizures, respiratory failure, AKI, metabolic acidosis)	ICU admission

Given the dose of ~5g and intentional nature of ingestion, ICU-level monitoring for at least 24 hours is recommended, even if initially asymptomatic.

Summary of Expected Clinical Course

Anticipated symptoms based on case reports and Tintinalli's:

Early (0-2h): Nausea, vomiting, diarrhea, headache, diaphoresis
Intermediate (2-12h): Muscle weakness, tremors, hypothermia, tachycardia
Severe (unpredictable): Seizures, encephalopathy, respiratory failure, AKI, metabolic acidosis, rhabdomyolysis

Recovery with aggressive supportive care is expected in most cases. One case report of a patient ingesting acetamiprid + fipronil (900mL at 4% concentration) demonstrated full recovery after prolonged ICU care [PMID: 40115001].

Key Reminder: No antidote exists. Do NOT give atropine (this is not an anticholinesterase poisoning - cholinergic excess is not the primary mechanism). Atropine is contraindicated.

References:

Tintinalli's Emergency Medicine, 9th Ed., p. 1346
Racha AS et al. Toxicol Rep. 2025 [PMID: 40115001]
Chen J et al. Toxicol Rep. 2023 [PMID: 37727219]
EPA/Product MSDS: No specific antidote; management symptom-based

should we give atropine

Finding Sources

The textbook sources are clear. Here is a definitive, well-reasoned answer:

No - Atropine is NOT Indicated for Acetamiprid Poisoning

This is a common and potentially dangerous clinical confusion. Here is why:

The Core Pharmacology

Feature	Organophosphates / Carbamates	Acetamiprid (Neonicotinoid)
Mechanism	Inhibit acetylcholinesterase → ACh accumulates → overstimulates both muscarinic AND nicotinic receptors	Direct nicotinic receptor agonist (no AChE inhibition)
Result	Cholinergic crisis (SLUDGE + nicotinic effects)	Purely nicotinic stimulation
Atropine role	Blocks muscarinic excess - lifesaving	No muscarinic excess exists - atropine cannot help

Why Atropine Does Not Work Here

Atropine is a competitive muscarinic receptor antagonist. It works in organophosphate poisoning because AChE inhibition causes acetylcholine to accumulate at both receptor types, and atropine counters the muscarinic overflow (bronchorrhea, bradycardia, hypersecretion).

In acetamiprid poisoning:

There is no AChE inhibition
There is no muscarinic excess
The toxicity is mediated purely through direct nicotinic receptor stimulation - tachycardia, muscle weakness, seizures, CNS stimulation

Atropine has no effect on nicotinic receptors. This is explicitly stated in the toxicology literature:

"Atropine can reverse the effects of muscarinic stimulation but NOT the muscle weakness resulting from nicotinic receptor stimulation." - Morgan & Mikhail's Clinical Anesthesiology

What About the Nicotinic Effects Then?

There is no drug that effectively reverses direct nicotinic agonism at the doses used clinically. Treatment remains purely supportive:

Seizures: Benzodiazepines
Muscle weakness/respiratory failure: Mechanical ventilation
Bradycardia/tachycardia: Treat hemodynamically as needed
Hypothermia: Active rewarming

Key Danger of Giving Atropine Here

Atropine would cause:

Tachycardia (already possibly present from nicotinic stimulation)
Urinary retention
Agitation/CNS excitation
Hyperthermia
All of which worsen the clinical picture - do not give it

Bottom line: Atropine is the correct antidote for organophosphate and carbamate poisoning. For neonicotinoids like acetamiprid, it is the wrong drug, offers no benefit, and can cause harm.

Morgan & Mikhail's Clinical Anesthesiology, 7e
Tintinalli's Emergency Medicine, 9th Ed., p. 1346
Katzung's Basic & Clinical Pharmacology, 16th Ed.

This is a shared conversation. Sign in to Orris to start your own chat.